Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 614.65
+5.90 (0.97%)
Jun 19, 2026, 3:30 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.28 billion as of June 18, 2026. Its market cap has increased by 12.92% in one year.
Market Cap
12.28B
Enterprise Value
9.91B
Revenue
6.71B
Ranking
n/a
PE Ratio
13.97
Stock Price
614.65
Market Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.28B, an increase of 8,738.59%. That is a compound annual growth rate of 22.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 12.28B | 26.85% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 37.67B |
| Solara Active Pharma Sciences | 27.34B |
| Indoco Remedies | 21.42B |
| Beta Drugs | 20.09B |
| Sakar Healthcare | 17.71B |
| Windlas Biotech | 16.67B |
| Ind-Swift Laboratories | 16.25B |
| Jagsonpal Pharmaceuticals | 14.14B |